A - AGILENT TECHNOLOGIES, INC.
Close
143.1
0 0%
Share volume: 78,979
Last Updated: Wed 15 Jan 2025 06:52:32 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.09%
PREVIOUS CLOSE
CHG
CHG%
$143.10
0.00
0.00%
View ratios
| Fiscal Date | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 | 2024-01-31 | 2024-04-30 | 2024-07-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 2024-03-04 | 2023-05-26 | 2023-08-30 | 2024-12-19 | 2024-03-04 | 2024-05-31 | 2024-08-29 | 2024-12-19 | |
| Assets | |||||||||
| Total Assets | 10.919 B | 10.792 B | 10.675 B | 10.763 B | 10.948 B | 10.856 B | 10.996 B | 11.846 B | |
| Current Assets | 4.078 B | 3.949 B | 4.030 B | 4.186 B | 4.338 B | 4.203 B | 4.256 B | 3.959 B | |
| Inventories | 1.111 B | 1.103 B | 1.072 B | 1.031 B | 1.033 B | 1.000 B | 978.000 M | 972.000 M | |
| Other Current Assets | 258.000 M | 270.000 M | 290.000 M | 274.000 M | 262.000 M | 283.000 M | 272.000 M | 334.000 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.250 B | 1.175 B | 1.329 B | 1.590 B | 1.748 B | 1.671 B | 1.779 B | 1.329 B | |
| Total Non-current Assets | 188.000 M | 186.000 M | 190.000 M | 164.000 M | 170.000 M | 177.000 M | 186.000 M | 175.000 M | |
| Property Plant Equipment | 1.147 B | 1.184 B | 1.211 B | 1.270 B | 1.314 B | 1.371 B | 1.446 B | 1.778 B | |
| Other Assets | 5.694 B | 5.659 B | 5.434 B | 5.307 B | 5.296 B | 5.282 B | 5.294 B | 6.109 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 10.919 B | 10.792 B | 10.675 B | 10.763 B | 10.948 B | 10.856 B | 10.996 B | 11.846 B | |
| Total liabilities | 5.310 B | 5.011 B | 5.117 B | 4.918 B | 4.760 B | 4.642 B | 5.093 B | 5.948 B | |
| Total current liabilities | 1.936 B | 1.666 B | 1.760 B | 1.603 B | 1.617 B | 1.958 B | 2.389 B | 1.895 B | |
| Accounts Payable | 540.000 M | 479.000 M | 452.000 M | 418.000 M | 488.000 M | 461.000 M | 497.000 M | 540.000 M | |
| Other liabilities | 542.000 M | 515.000 M | 531.000 M | 477.000 M | 486.000 M | 449.000 M | 471.000 M | 578.000 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 2.733 B | 2.733 B | 2.734 B | 2.735 B | 2.555 B | 2.136 B | 2.137 B | 3.345 B | |
| Other liabilities | 542.000 M | 515.000 M | 531.000 M | 477.000 M | 486.000 M | 449.000 M | 471.000 M | 578.000 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 5.609 B | 5.781 B | 5.558 B | 5.845 B | 6.188 B | 6.214 B | 5.903 B | 5.898 B | |
| Common stock | 5.348 B | 5.363 B | 5.385 B | 5.390 B | 5.443 B | 5.461 B | 5.461 B | 5.453 B | |
| Retained earnings | 541.000 M | 700.000 M | 444.000 M | 782.000 M | 1.061 B | 1.090 B | 773.000 M | 750.000 M |